Yael Kenen
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Yael Kenen is currently the Vice President-Clinical Affairs at Epitomee Medical Ltd. Prior to this, Yael worked as the Chief Executive Officer at Lacrima Medical Ltd. and as the Chief Operating Officer at TransPharma Medical Ltd. Yael holds an MBA from Technion-Israel Institute of Technology and a doctorate from The Hebrew University of Jerusalem.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
EPITOMEE MEDICAL LTD -.--% | 2026-05-12 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| EPITOMEE MEDICAL LTD | Teknisk/Vetenskaplig/F&U Direktör | 2020-01-01 |
| Företag | Position | Slut |
|---|---|---|
Lacrima Medical Ltd.
Lacrima Medical Ltd. Medical SpecialtiesHealth Technology Develops medical treatment device for dry eye disease | Verkställande Direktör | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Provides development and commercialization of drugs | Verksamhetschef | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Provides development and commercialization of drugs | Health Technology |
Epitomee Medical Ltd.
Epitomee Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medical devices for obesity | Health Technology |
Lacrima Medical Ltd.
Lacrima Medical Ltd. Medical SpecialtiesHealth Technology Develops medical treatment device for dry eye disease | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån